American Century Companies’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.67M Sell
187,503
-87,418
-32% -$2.05M ﹤0.01% 1909
2026
Q1
$3.85M Buy
274,921
+160,153
+140% +$2.16M ﹤0.01% 1889
2025
Q4
$1.29M Buy
114,768
+308
+0.3% +$3.52K ﹤0.01% 2242
2025
Q3
$1.32M Sell
114,460
-14,317
-11% -$168K ﹤0.01% 2209
2025
Q2
$1.58M Buy
128,777
+5,830
+5% +$73.3K ﹤0.01% 2111
2025
Q1
$1.76M Buy
122,947
+17,835
+17% +$278K ﹤0.01% 2032
2024
Q4
$1.67M Buy
105,112
+9,249
+10% +$183K ﹤0.01% 2068
2024
Q3
$2.3M Buy
95,863
+12,933
+16% +$296K ﹤0.01% 1908
2024
Q2
$1.65M Buy
82,930
+8,929
+12% +$174K ﹤0.01% 1979
2024
Q1
$1.47M Buy
74,001
+2,152
+3% +$41.6K ﹤0.01% 1997
2023
Q4
$1.61M Buy
71,849
+7,007
+11% +$145K ﹤0.01% 1881
2023
Q3
$1.31M Buy
64,842
+27,811
+75% +$630K ﹤0.01% 1887
2023
Q2
$947K Buy
37,031
+429
+1% +$11.3K ﹤0.01% 1970
2023
Q1
$1.09M Buy
36,602
+9,015
+33% +$262K ﹤0.01% 1830
2022
Q4
$747K Buy
27,587
+4,486
+19% +$110K ﹤0.01% 1898
2022
Q3
$503K Buy
23,101
+1,307
+6% +$34.1K ﹤0.01% 1951
2022
Q2
$596K Buy
+21,794
New +$626K ﹤0.01% 1852
2017
Q4
– Sell
-121,628
Closed -$5.48M – 1269
2017
Q3
$5.48M Buy
121,628
+78,423
+182% +$3.35M 0.01% 830
2017
Q2
$1.7M Hold
43,205
– – ﹤0.01% 1063
2017
Q1
$1.65M Buy
+43,205
New +$1.68M ﹤0.01% 1072

Other funds holding AVNS

American Century Companies's AVNS Position: Q2 2026 in Review

American Century Companies reduced its Avanos Medical (AVNS) stake by 32% in Q2 2026, selling an estimated $2.05M and leaving 187,503 shares worth $4.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

American Century Companies first reported a position in AVNS in Q1 2017 and has held it in 20 quarters since. The position peaked at $5.48M in Q3 2017. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • American Century Companies held 187,503 shares of Avanos Medical worth $4.67M as of Q2 2026.
  • American Century Companies sold 87,418 Avanos Medical shares in Q2 2026, an estimated $2.05M.
  • Avanos Medical made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1909 holding.
  • American Century Companies first reported a position in Avanos Medical in Q1 2017 and has held it in 20 quarters since.
  • American Century Companies's Avanos Medical position peaked at $5.48M in Q3 2017.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.